|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,931.50 GBX | -0.44% |
|
+0.63% | +5.86% |
| 07-30 | Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US | RE |
| 07-30 | GSK global supply chain director sells 38,000 shares | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 104B | |||||
| 1,024B | |||||
| 618B | |||||
| 443B | |||||
| 349B | |||||
| 297B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
